B Evidence Grade B Graded under review Safe to Cite Recent

200

200 -- fda enforcement letters count for FDA prescription drug advertising and promotion (2025)

2025  · King & Spalding

Cite this stat Share How we verify
Attribution: King & Spalding View source
Lighthouse Research Team
Last verified:  ·  How we verify data →
Source verified Evidence graded
Value
200
Unit
Count
Data Vintage
2025
Entity
FDA prescription drug advertising and promotion
B
Strong, reliable evidence

Sourced from a well-regarded research firm or industry leader with transparent methodology and a reasonably large sample.

61/100 confidence

Single source - not yet corroborated

Extraction
75
Source Trust
60
Citation Chain
20
Independence
30
Methodology
45
Freshness
95
King & Spalding Primary Tier B
https://www.revisto.com/news/how-to-reduce-rework-in-the-mlr-review-process ↗
Confidence: 53/100 Vintage: 2025 Channel: Deep Crawl
Source Article
How to Reduce Rework in the MLR Review Process
Key TakeawaysMost MLR rework is preventable: quality failures almost always originate before content reaches the formal MLR review process. A structured pre-MLR review catches claim, fair balance, and annotation issues before they reach reviewers. First-time-right approvals require upstream discipli…
Original Research
King & Spalding · Original study ↗

Year-in-review enforcement analysis by King & Spalding, cited by Revisto; surge concentrated in final quarter of 2025

Methodology documented
Industryhealthcare
Plain Text
FDA prescription drug advertising and promotion: 200 fda enforcement letters count. Source: King & Spalding (2025). Via Lighthouse Intelligence -- https://lighthousedata.io/data/fda-enforcement-letters-pharma-promotion-2025
HTML Embed
<blockquote cite="https://lighthousedata.io/data/fda-enforcement-letters-pharma-promotion-2025" style="border-left:3px solid #2563eb;padding:12px 16px;margin:16px 0;font-family:system-ui,sans-serif;background:#f0f4ff;"><strong>200</strong> -- fda enforcement letters count for FDA prescription drug advertising and promotion<br><small>Source: King & Spalding (2025) · <a href="https://lighthousedata.io/data/fda-enforcement-letters-pharma-promotion-2025" target="_blank" rel="noopener">Lighthouse Intelligence</a></small></blockquote>
Share
Share on X Share on LinkedIn

Use this data in your work

Copy the citation, embed the widget, or explore thousands more verified marketing statistics -- all free.

Copy citation Explore similar stats →